BGM (BGM) | Stock Overview & Key Data

BGM Group Ltd. | Healthcare

$14.66

14.17%

| BGM Stock Comparison:

BGM vs Zoetis BGM vs Haleon Plc - ADR BGM vs Kiniksa BGM vs Supernus BGM vs Bausch Health BGM vs S&P 500 | Market

BGM Performance Comparison

Loading chart data...

BGM

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $12.88 High: $14.70

on May 23, 2025

52 Week Range

Low: $2.70 High: $14.78

on May 23, 2024

on January 8, 2025

All-Time High: $110.00 on January 11, 2021

Key Statistics

Market Cap i $2.3B

EPS i -0.20

P/E Ratio (TTM) i 15.00

Forward P/E i N/A

P/B Ratio i 2.09

PEG Ratio i N/A

Div. Yield i 0.00%

ROE i -16.52%

Beta i 1.457

Debt to Equity i 0.22

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i -5.41%

Profit Margin i -26.32%

Returns and Earnings

Return on Assets (TTM) i -3.84%

Return on Equity (TTM) i -16.52%

EBITDA i $1.8M

Net Income (TTM) i $-7.9M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
BGM BGM	2.27B Mid-cap	16.91%	34.99%	46.89%	108.24%	63.98%	234.10%	65.71%	-66.86%
Zoetis ZTS	71.48B Large-cap	-0.28%	7.73%	-1.65%	-9.03%	-0.02%	-4.42%	-5.54%	16.62%
Haleon Plc - ADR HLN	49.99B Large-cap	3.15%	8.90%	9.75%	16.28%	18.01%	32.94%	50.34%	50.34%
Kiniksa KNSA	1.90B Small-cap	2.44%	28.78%	36.98%	23.35%	34.85%	41.21%	233.33%	28.89%
Supernus SUPN	1.81B Small-cap	-3.98%	4.09%	-1.77%	-11.08%	-11.89%	16.54%	12.89%	32.92%
Bausch Health BHC	1.66B Small-cap	-4.71%	-13.93%	-37.94%	-44.03%	-43.95%	-30.03%	-54.91%	-75.92%

Ownership & Short Interest

Insider Ownership i 7.29%

Institutional Ownership i 0.00%

Shares Short i 7K

Short Ratio i 0.17

Short % of Shares Outstanding i 0.43%

Average 10-Day Volume i 3K

Average 90-Day Volume i 22K

BGM Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in BGM would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BGM's 52-week high and low?

In the last 52 weeks, BGM reached a high of $14.78 (on January 8, 2025) and a low of $2.70 (on May 23, 2024).

What is the market cap and P/E ratio for BGM?

Curious about BGM's size and valuation? Its market capitalization stands at 2.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.00, and the forward P/E (looking ahead) is N/A.

Does BGM pay dividends? If so, what's the yield?

As for dividends, BGM isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are BGM's main competitors or similar companies to consider before investing?

When looking at BGM, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	71.48B	Healthcare	Drug Manufacturers - Specialty & Generic	-4.42%	-5.54%
Haleon Plc - ADR HLN	49.99B	Healthcare	Drug Manufacturers - Specialty & Generic	32.94%	50.34%
Kiniksa KNSA	1.90B	Healthcare	Drug Manufacturers - Specialty & Generic	41.21%	233.33%
Supernus SUPN	1.81B	Healthcare	Drug Manufacturers - Specialty & Generic	16.54%	12.89%
Bausch Health BHC	1.66B	Healthcare	Drug Manufacturers - Specialty & Generic	-30.03%	-54.91%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for BGM Group Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of BGM's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -16.52%, the Debt to Equity ratio from the most recent quarter is 0.22, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for BGM?

Looking at BGM's growth, its revenue over the trailing twelve months (TTM) was $30M. Compared to the same quarter last year (YoY), quarterly revenue grew by -56.90%, and quarterly earnings saw a YoY growth of -16.40%.

How much of BGM stock is held by insiders and institutions?

Wondering who owns BGM stock? Company insiders (like executives and directors) hold about 7.29% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.